Subscribe
Israel-Hamas Conflict
US Economy
US Immigration
Volleyball
Donald Trump
Republican Party
Kamala Harris
Soccer
US Politics
Immigration
NFL
Oprah Winfrey
Federal Reserve
Published

Potential Cancer Breakthrough: Common Antidepressant Effective Against Brain Tumors

Summary by Sci Tech Daily
Vortioxetine, an antidepressant, shows promise against glioblastoma in lab tests conducted by ETH Zurich, leading to forthcoming clinical trials. Glioblastoma is an incurable and fatal type of brain cancer. In a large-scale drug screening, the antidepressant, vortioxetine emerged as one of the most effective agents against these types of cancer cells. Clinical trials are already [...]

0 Articles

All
Left
Center
Right
Evening StandardEvening Standard

Common antidepressant ‘unexpectedly effective’ against aggressive brain tumours

Findings raise hope for treating a disease which as a poor survival rate.

·London, United Kingdom
Read Full Article
Sci Tech DailySci Tech Daily

Potential Cancer Breakthrough: Common Antidepressant Effective Against Brain Tumors

Vortioxetine, an antidepressant, shows promise against glioblastoma in lab tests conducted by ETH Zurich, leading to forthcoming clinical trials. Glioblastoma is an incurable and fatal type of brain cancer. In a large-scale drug screening, the antidepressant, vortioxetine emerged as one of the most effective agents against these types of cancer cells. Clinical trials are already [...]

Read Full Article
perspectivemedia.comperspectivemedia.com

Common antidepressant ‘unexpectedly effective’ against aggressive brain tumours

Findings raise hope for treating a disease which as a poor survival rate. A cheap and widely available antidepressant has shown to be “unexpectedly effective” in treating aggressive brain tumours, scientists have said. Vortioxetine is recommended by the National Institute for Health and Care Excellence (Nice) for adults who have major depressive episodes. But lab tests on cancer cells have shown it was “unexpectedly effective” in treating gliob…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Sources are mostly out of (0)

Similar News Topics

ZurichZurich
London, EnglandLondon, England
Trending Topics
Ground News logo
App Store IconPlay Store Icon
CompanyAboutHistoryMissionBlogTestimonialsGroup SubscriptionsSubscribeGiftFree TrialCareersAffiliates
HelpHelp CenterFAQContact UsFor Educators/LibrariesMedia Bias RatingsOwnership and Factuality RatingsReferral CodeNews SourcesTopics
ToolsAppBrowser ExtensionDaily NewsletterBlindspot Report NewsletterBurst Your Bubble NewsletterTimelines
DonatePrivacy PolicyManage CookiesTerms and Conditions
© 2024 Snapwise Inc
News
For You
Search
BlindspotLocal